Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    November 2021
  1. OTOBE Y, Rhee CM, Nguyen M, Kalantar-Zadeh K, et al
    Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients.
    Curr Opin Nephrol Hypertens. 2021 Nov 11. pii: 00041552-900000000-98950.
    PubMed     Abstract available


  2. AHDOOT RS, Kalantar-Zadeh K, Burton JO, Lockwood MB, et al
    Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98960.
    PubMed     Abstract available


  3. KALANTAR-ZADEH K, Rhee CM, Joshi S, Brown-Tortorici A, et al
    Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes.
    Curr Opin Nephrol Hypertens. 2021 Nov 8. pii: 00041552-900000000-98952.
    PubMed     Abstract available


  4. TANTISATTAMO E, Hamiduzzaman A, Sohn P, Ahdoot R, et al
    Reconciling Systolic Blood Pressure Intervention Trial with Eighth Joint National Commission: a nuanced view of optimal hypertension control in the chronic kidney disease population.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98955.
    PubMed     Abstract available


  5. TANTISATTAMO E, Kalantar-Zadeh K, Molnar MZ
    Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98954.
    PubMed     Abstract available


  6. RHEE CM, Kalantar-Zadeh K, Tuttle KR
    Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Nov 5. pii: 00041552-900000000-98953.
    PubMed     Abstract available


  7. ALSAAD R, Chen X, McAdams-DeMarco M
    The clinical application of frailty in nephrology and transplantation.
    Curr Opin Nephrol Hypertens. 2021;30:593-599.
    PubMed     Abstract available


  8. STEWART P, Stewart J
    Noninvasive continuous intradialytic blood pressure monitoring: the key to improving haemodynamic stability.
    Curr Opin Nephrol Hypertens. 2021;30:559-562.
    PubMed     Abstract available


    September 2021
  9. CANAUD B
    Recent advances in dialysis membranes.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98966.
    PubMed     Abstract available


  10. ZABETIAN A, Coca SG
    Plasma and urine biomarkers in chronic kidney disease: closer to clinical application.
    Curr Opin Nephrol Hypertens. 2021 Sep 1. pii: 00041552-900000000-98967.
    PubMed     Abstract available


    August 2021
  11. TIAN N, Chen N, Li PK
    Depression in dialysis.
    Curr Opin Nephrol Hypertens. 2021 Aug 26. pii: 00041552-900000000-98971.
    PubMed     Abstract available


  12. LIGHTFOOT CJ, Howell M, Smith AC
    How to assess quality of life in persons with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Aug 23. pii: 00041552-900000000-98972.
    PubMed     Abstract available


    July 2021
  13. SINHA S, Raggi P, Chertow GM
    SNF472: mechanism of action and results from clinical trials.
    Curr Opin Nephrol Hypertens. 2021;30:424-429.
    PubMed     Abstract available


    June 2021
  14. SAEED F, Shah AY, Allen RJ, Epstein RM, et al
    Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature.
    Curr Opin Nephrol Hypertens. 2021 Jun 18. pii: 00041552-900000000-98977.
    PubMed     Abstract available


    May 2021
  15. COHEN-BUCAY A, Francis JM, Gordon CE
    Progress in hepatitis C virus management in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 28. pii: 00041552-900000000-98979.
    PubMed     Abstract available


  16. PARVATHAREDDY VP, Ella KM, Shah M, Navaneethan SD, et al
    Treatment options for managing obesity in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 25. pii: 00041552-900000000-98980.
    PubMed     Abstract available


  17. SMEIJER JD, Kohan DE, Webb DJ, Dhaun N, et al
    Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 May 10. pii: 00041552-900000000-98984.
    PubMed     Abstract available


  18. CHALUPSKY M, Goodson DA, Gamboa JL, Roshanravan B, et al
    New insights into muscle function in chronic kidney disease and metabolic acidosis.
    Curr Opin Nephrol Hypertens. 2021;30:369-376.
    PubMed     Abstract available


  19. VLASSCHAERT C, Sidhu B, Silver SA
    Sodium/glucose cotransporter 2 inhibitors in chronic kidney disease and heart failure: ready for prime time in patients without diabetes.
    Curr Opin Nephrol Hypertens. 2021;30:361-368.
    PubMed     Abstract available


  20. ARIF H, Yadav A
    Approach to stable angina in patients with advanced chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021;30:339-345.
    PubMed     Abstract available


    April 2021
  21. DAMRATH JG, Creecy A, Wallace JM, Moe SM, et al
    The impact of advanced glycation end products on bone properties in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Apr 28. pii: 00041552-900000000-98985.
    PubMed     Abstract available


    January 2021
  22. CLARK-CUTAIA MN, Rivera E, Iroegbu C, Squires A, et al
    Disparities in chronic kidney disease-the state of the evidence.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99003.
    PubMed     Abstract available


  23. KOURI AM, Rheault MN
    Cardiovascular disease in children with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2021 Jan 13. pii: 00041552-900000000-99002.
    PubMed     Abstract available


  24. PREMACHANDRA KH, Day RO, Roberts DM
    Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum.
    Curr Opin Nephrol Hypertens. 2021;Publish Ahead of Print.
    PubMed     Abstract available


    December 2020
  25. NAIR D, Malhotra S, Lupu D, Harbert G, et al
    Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  26. SOOMRO QH, Charytan DM
    Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  27. ZARANTONELLO D, Rhee CM, Kalantar-Zadeh K, Brunori G, et al
    Novel conservative management of chronic kidney disease via dialysis-free interventions.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000670.
    PubMed     Abstract available


  28. TANTISATTAMO E, Kalantar-Zadeh K
    Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000677.
    PubMed    


  29. STREJA E, Norris KC, Budoff MJ, Hashemi L, et al
    The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000672.
    PubMed     Abstract available


  30. FERREY AJ, Hanna R, Reddy UG, Tantisattamo E, et al
    Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000671.
    PubMed     Abstract available


  31. TANTISATTAMO E, Leventhal JR, Mathew JM, Gallon L, et al
    Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000666.
    PubMed     Abstract available


  32. HANNA RM, Ferrey A, Rhee CM, Sam R, et al
    Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000658.
    PubMed     Abstract available


  33. TANTISATTAMO E, Kalantar-Zadeh K, Halleck F, Duettmann W, et al
    Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000673.
    PubMed     Abstract available


  34. ONG SC, Rhee CM
    Novel management of diabetes in kidney transplantation.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000665.
    PubMed     Abstract available


  35. MUREA M
    Precision medicine approach to dialysis including incremental and decremental dialysis regimens.
    Curr Opin Nephrol Hypertens. 2020 Nov 6. doi: 10.1097/MNH.0000000000000667.
    PubMed     Abstract available


  36. SUMIDA K, Lau WL, Kovesdy CP, Kalantar-Zadeh K, et al
    Microbiome modulation as a novel therapeutic approach in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000661.
    PubMed     Abstract available


  37. JUDGE PK, Haynes R
    taleNeprilysin and Neprilysin inhibition in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2020 Nov 2. doi: 10.1097/MNH.0000000000000659.
    PubMed     Abstract available


  38. HUR L, McIntyre CW
    Current and novel imaging techniques to evaluate myocardial dysfunction during hemodialysis.
    Curr Opin Nephrol Hypertens. 2020;29:555-563.
    PubMed     Abstract available


  39. CHUKWU CA, Middleton R, Kalra PA
    Recurrent glomerulonephritis after renal transplantation.
    Curr Opin Nephrol Hypertens. 2020;29:636-644.
    PubMed     Abstract available


  40. VIRAMONTES-HORNER D, Taal MW
    Nutritional status assessment: a neglected biomarker in persons with end-stage kidney disease.
    Curr Opin Nephrol Hypertens. 2020;29:547-554.
    PubMed     Abstract available


    January 2020
  41. KELLER RW JR, Kopple JD, Kalantar-Zadeh K
    Perspiration interventions for conservative management of kidney disease and uremia.
    Curr Opin Nephrol Hypertens. 2020;29:57-63.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: